ReviewCancers2021
Delirium in Palliative Care.
Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Prevalence, associated factors, and prognostic impact of delirium in advanced cancer patients in acute palliative care units: a prospective observational study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- End-of-life dreams and visions in a patient with delirium: A Brazilian case report and narrative review.Palliative & supportive care · 2025Review
- Frequency and predictors of palliative sedation among patients with cancer who died in a specialist inpatient palliative care unit: a retrospective study.BMC palliative care · 2025Article
- Delirium pathophysiology in cancer: neurofilament light chain biomarker - narrative review.BMJ supportive & palliative care · 2025Review
- What are the experiences and support needs of district nurses caring for terminally ill people with delirium at home? A qualitative study.BMC palliative care · 2025Article
- Article
- Having hard conversations: Advance care planning, serious illness conversations, and goals of care discussions with oncology patients.Canadian family physician Medecin de famille canadien · 2025Article
- Unscheduled Hospital Admission as a Prognostic Factor in the Oncologic Patient: A Retrospective Study.Cureus · 2024Article
- Reply to: Frailty and ethics at the end of life: The importance of a comprehensive assessment.Journal of the American Geriatrics Society · 2024Article
- Drugs, delirium, and ethics at the end of life.Journal of the American Geriatrics Society · 2024Article
- The 4AT, a rapid delirium detection tool for use in hospice inpatient units: Findings from a validation study.Palliative medicine · 2024Article
- Frequency of vaccine hesitancy among patients with advanced cancer.Palliative & supportive care · 2024Article
- Addressing Challenges With Sedation in End-of-Life Care.Journal of pain and symptom management · 2024Article
- Opioid-induced Neurotoxicity in Patients with Cancer Pain.Current treatment options in oncology · 2023Review
- Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Delirium, a widespread neuropsychiatric disorder in patients with terminal diseases, is associated with increased morbidity and mortality, profoundly impacting patients, their families, and caregivers. Although frequently missed, the effective recognition of delirium demands attention and commitment. Reversibility is frequently not achievable. Non-pharmacological and pharmacological interventions are commonly used but largely unproven. Palliative sedation, although controversial, should be considered for refractory delirium. Psychological assistance should be available to patients and their families at all times.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.